The weekly litigation news digest is live. Subscribe now

IP Verse

Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions - EP3320919

The patent EP3320919 was granted to Boehringer Ingelheim on May 27, 2020. The application was filed on Dec 28, 2006 under application number EP17208901A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3320919

BOEHRINGER INGELHEIM
Application Number
EP17208901A
Filing Date
Dec 28, 2006
Status
Granted And Under Opposition
Apr 24, 2020
Publication Date
May 27, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ELANCOFeb 25, 2021POTTER CLARKSONADMISSIBLE
LABORATORIOS HIPRAFeb 24, 2021GRUNECKER PATENTADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONCA2784260
OPPOSITIONEP0784685
OPPOSITIONEP1926496
OPPOSITIONGB2282811
OPPOSITIONUS2003170270
OPPOSITIONUS6001370
OPPOSITIONUS60755015
OPPOSITIONUS6703023
OPPOSITIONUS7122192
OPPOSITIONWO0001409
OPPOSITIONWO0116330
OPPOSITIONWO2005009462
OPPOSITIONWO2006072065
OPPOSITIONWO2007076520
OPPOSITIONWO9307898
OPPOSITIONWO9418311

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents